Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats
Holly S. Hake, Jazmyne K.P. Davis, River R. Wood, et al.
Physiology & Behavior (2018) Vol. 199, pp. 343-350
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1025-1033
Open Access | Times Cited: 693
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 5, pp. 891-900
Open Access | Times Cited: 185
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Jennifer Mitchell, Michael P. Bogenschutz, Alia Lilienstein, et al.
FOCUS The Journal of Lifelong Learning in Psychiatry (2023) Vol. 21, Iss. 3, pp. 315-328
Open Access | Times Cited: 61
MDMA and MDMA-Assisted Therapy
Aaron Wolfgang, Gregory A. Fonzo, Joshua C. Gray, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 79-103
Closed Access | Times Cited: 4
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
Alberto Melani, Marco Bonaso, Letizia Biso, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
S. Parker Singleton, Julie B. Wang, Michael C. Mithoefer, et al.
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 22
MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections
Manoj K. Doss, Jessica Weafer, David A. Gallo, et al.
Neuropsychopharmacology (2017) Vol. 43, Iss. 4, pp. 791-800
Open Access | Times Cited: 67
A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults
Jessica L. Maples‐Keller, Seth D. Norrholm, Mark Burton, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 368-377
Open Access | Times Cited: 35
Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice
Błażej D. Pędzich, Sarah Rubens, Mehdi Sekssaoui, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1304-1314
Open Access | Times Cited: 33
Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects
Patrick Vizeli, Isabelle Straumann, Urs Duthaler, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28
Geraniol attenuates behavioral and neurochemical impairments by inhibitions of HPA-axis and oxido-inflammatory perturbations in mice exposed to post-traumatic stress disorder
Benneth Ben‐Azu, Olusegun G. Adebayo, Emuesiri Goodies Moke, et al.
Journal of Psychiatric Research (2023) Vol. 168, pp. 165-175
Closed Access | Times Cited: 20
A New Cu2+‐Binding 1,3‐Benzodioxole‐Contaning N‐Acylhydrazone Protects Saccharomyces cerevisiae Cells from Oxidative Stress
Barbara Marinho Barbosa, Daniele C. Pires, Antal Galvácsi, et al.
ChemistrySelect (2025) Vol. 10, Iss. 6
Closed Access
Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond
Shuai Hu, Cong Lin, Hongshuang Wang, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial
Terence H. W. Ching, Monnica T. Williams, Julie B. Wang, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 974-986
Closed Access | Times Cited: 20
MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
Mesud Sarmanlu, Kim P. C. Kuypers, Patrick Vizeli, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 128, pp. 110843-110843
Open Access | Times Cited: 11
Memory Trace for Fear Extinction: Fragile yet Reinforceable
Ying Liu, Shuai Ye, Xin-Ni Li, et al.
Neuroscience Bulletin (2023) Vol. 40, Iss. 6, pp. 777-794
Open Access | Times Cited: 11
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes
Grant Jones
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 61-69
Closed Access | Times Cited: 18
The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics
Jared VanderZwaag, Torin Halvorson, Kira Dolhan, et al.
Neurochemical Research (2022) Vol. 48, Iss. 4, pp. 1129-1166
Closed Access | Times Cited: 17
Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction
Emilija Glavonic, Miloš Mitić, Miroslav Adžić
Journal of Neuroscience Research (2022) Vol. 100, Iss. 4, pp. 947-969
Closed Access | Times Cited: 16
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Samuli Kangaslampi, Josjan Zijlmans
European Child & Adolescent Psychiatry (2023)
Open Access | Times Cited: 9
A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects
Abshir S. Adam, Kayleigh S. LaMalfa, Yasaman Razavi, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 2, pp. 96-108
Open Access | Times Cited: 3
The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials
Jianhua Yang, Ni Wang, Wulin Luo, et al.
Psychiatry Research (2024) Vol. 339, pp. 116043-116043
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top